27-Jan-2026
TipRanks (Mon, 26-Jan 6:08 AM ET)
Edwards Lifesciences (EW) Gets a Buy from Jefferies
TipRanks (Fri, 23-Jan 9:46 AM ET)
AI Diagnostics: The End of the High-Cost Imaging Era
Globe Newswire (Fri, 16-Jan 11:40 AM ET)
Edwards Comments on JenaValve Acquisition
Business Wire (Fri, 9-Jan 6:48 PM ET)
PRNewswire (Wed, 24-Dec 12:45 PM ET)
Business Wire (Tue, 23-Dec 9:00 AM ET)
Edwards Lifesciences Sets Stage for Key Insights at J.P. Morgan Healthcare Conference
Market Chameleon (Thu, 18-Dec 3:23 AM ET)
Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
Business Wire (Thu, 18-Dec 7:05 AM ET)
Business Wire (Thu, 4-Dec 9:00 AM ET)
Business Wire (Sun, 9-Nov 4:00 PM ET)
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US.
Edwards Lifesciences trades on the NYSE stock market under the symbol EW.
As of January 27, 2026, EW stock price declined to $83.60 with 1,846,903 million shares trading.
EW has a beta of 0.52, meaning it tends to be less sensitive to market movements. EW has a correlation of 0.15 to the broad based SPY ETF.
EW has a market cap of $48.51 billion. This is considered a Large Cap stock.
Last quarter Edwards Lifesciences reported $2 billion in Revenue and $.67 earnings per share. This beat revenue expectation by $55 million and exceeded earnings estimates by $.08.
In the last 3 years, EW traded as high as $96.12 and as low as $58.93.
The top ETF exchange traded funds that EW belongs to (by Net Assets): VTI, VOO, VO, IVV, SPY.
EW has outperformed the market in the last year with a return of +20.8%, while the SPY ETF gained +17.3%. In the last 3 month period, EW beat the market returning +3.4%, while SPY returned +1.8%. However, in the most recent 2 weeks EW has underperformed the stock market by returning -0.3%, while SPY returned +0.2%.
EW support price is $83.07 and resistance is $85.48 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that EW shares will trade within this expected range on the day.
